Review Article
Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Table 2
Results of sensitivity analysis.
| Study excluded | HR (95% CI) | | |
| Yoshida et al. 2008 | 0.56 (0.45–0.70) | 0.0% | 0.695 | Zhou et al. 2015 | 0.54 (0.41–0.70) | 0.0% | 0.733 | Sohn et al. 2016 | 0.60 (0.48–0.74) | 0.0% | 0.802 | Xu et al. 2014 | 0.58 (0.46–0.73) | 0.0% | 0.644 | Zhu et al. 2015 | 0.56 (0.45–0.70) | 0.0% | 0.669 | Toyoda et al. 2012 | 0.59 (0.47–0.73) | 0.0% | 0.775 |
|
|
HR: hazard ratio.
|